UBX ( NASDAQ BIOTECH PENNY) crushes earnings and news catalyst

UBX

and rises over 100 % in premarket, Has a new product
for macular degeneration, a widespread medical problem
affecting vision in the elderly which is increasing
in incidence. The earning beat was significant.

Chart demonstrates the uptrend and midrange
RSI but does not show today's premarket.

40 % rise in the week leading up to earnings and now parabolic.
doubling overnight.

* Get in the party now, don't be late. If you are
late stay home"

( not a recommendation to buy only education)